BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21699772)

  • 1. Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool.
    Feng Y; Bommer GT; Zhao J; Green M; Sands E; Zhai Y; Brown K; Burberry A; Cho KR; Fearon ER
    Gastroenterology; 2011 Sep; 141(3):1003-1013.e1-10. PubMed ID: 21699772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.
    Bongers G; Muniz LR; Pacer ME; Iuga AC; Thirunarayanan N; Slinger E; Smit MJ; Reddy EP; Mayer L; Furtado GC; Harpaz N; Lira SA
    Gastroenterology; 2012 Sep; 143(3):730-740. PubMed ID: 22643351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPing the role of Kras mutations in hyperplastic polyps.
    Barrett T; Li L
    Gastroenterology; 2011 Sep; 141(3):799-801. PubMed ID: 21791211
    [No Abstract]   [Full Text] [Related]  

  • 7. Benign serrated colorectal fibroblastic polyps/intramucosal perineuriomas are true mixed epithelial-stromal polyps (hybrid hyperplastic polyp/mucosal perineurioma) with frequent BRAF mutations.
    Agaimy A; Stoehr R; Vieth M; Hartmann A
    Am J Surg Pathol; 2010 Nov; 34(11):1663-71. PubMed ID: 20962618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.
    Rosty C; Buchanan DD; Walsh MD; Pearson SA; Pavluk E; Walters RJ; Clendenning M; Spring KJ; Jenkins MA; Win AK; Hopper JL; Sweet K; Frankel WL; Aronson M; Gallinger S; Goldblatt J; Woodall S; Arnold J; Walker NI; Jass JR; Parry S; Young JP
    Am J Surg Pathol; 2012 Jun; 36(6):876-82. PubMed ID: 22510757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic and molecular analyses of colonic perineurial-like proliferations in serrated polyps: perineurial-like stromal proliferations are seen in sessile serrated adenomas.
    Pai RK; Mojtahed A; Rouse RV; Soetikno RM; Kaltenbach T; Ma L; Arber DA; Plesec TP; Goldblum JR; Pai RK
    Am J Surg Pathol; 2011 Sep; 35(9):1373-80. PubMed ID: 21836484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
    Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
    Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Diffusion-like Process Accommodates New Crypts During Clonal Expansion in Human Colonic Epithelium.
    Olpe C; Khamis D; Chukanova M; Skoufou-Papoutsaki N; Kemp R; Marks K; Tatton C; Lindskog C; Nicholson A; Brunton-Sim R; Malhotra S; Ten Hoopen R; Stanley R; Winton DJ; Morrissey E
    Gastroenterology; 2021 Aug; 161(2):548-559.e23. PubMed ID: 33895166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and molecular features of colorectal serrated neoplasias with different mucosal crypt patterns.
    Yano Y; Konishi K; Yamochi T; Katagiri A; Nozawa H; Suzuki H; Toyota M; Kubota Y; Muramoto T; Kobayashi Y; Tojo M; Konda K; Makino R; Kaneko K; Yoshikawa N; Ota H; Imawari M
    Am J Gastroenterol; 2011 Jul; 106(7):1351-8. PubMed ID: 21427714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.
    Yang S; Farraye FA; Mack C; Posnik O; O'Brien MJ
    Am J Surg Pathol; 2004 Nov; 28(11):1452-9. PubMed ID: 15489648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
    Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
    J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
    Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
    Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular classification and genetic pathways in hyperplastic polyposis syndrome.
    Carvajal-Carmona LG; Howarth KM; Lockett M; Polanco-Echeverry GM; Volikos E; Gorman M; Barclay E; Martin L; Jones AM; Saunders B; Guenther T; Donaldson A; Paterson J; Frayling I; Novelli MR; Phillips R; Thomas HJ; Silver A; Atkin W; Tomlinson IP
    J Pathol; 2007 Aug; 212(4):378-85. PubMed ID: 17503413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.
    Hardiman KM; Liu J; Feng Y; Greenson JK; Fearon ER
    PLoS One; 2014; 9(4):e96023. PubMed ID: 24763434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Abelson interactor 1 (Abi1) correlates with inflammation, KRAS mutation and adenomatous change during colonic carcinogenesis.
    Steinestel K; Brüderlein S; Steinestel J; Märkl B; Schwerer MJ; Arndt A; Kraft K; Pröpper C; Möller P
    PLoS One; 2012; 7(7):e40671. PubMed ID: 22808230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of HES1 expression is associated with extracellular matrix remodeling and tumor immune suppression in KRAS mutant colon adenocarcinomas.
    Wang L; Gu W; Zou B; Kalady M; Xin W; Zhou L
    Sci Rep; 2023 Sep; 13(1):15999. PubMed ID: 37749297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characteristics of colorectal hyperplastic polyp subgroups.
    Ünlü M; Uzun E; Bengi G; Sağol Ö; Sarıoğlu S
    Turk J Gastroenterol; 2020 Aug; 31(8):573-580. PubMed ID: 32915145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.